Form EFFECT Indaptus Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | August 25, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NewPower Worldwide Expands Credit Facility to $750 Million to Support Global Growth and Customer Demand
- RHINOSHIELD AirX Sets GUINNESS WORLD RECORDS™ Title in Record-Breaking Near-Space Drop Challenge
- TraceLink Wins Global AI Award for Advancing the Agentic Supply Chain Operating Model
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
